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Abstract
Objectives To assess health-related quality of life (HRQoL) across three renal replacement therapy modalities (preemptive 
transplant, non-preemptive transplant, and dialysis) in comparison with the healthy norm and other chronic health conditions, 
and to explore related patient factors.
Study design All prevalent end-stage renal disease (ESRD) patients aged 8–18 years who spent at least 6 months on their 
current treatment modality in the Netherlands, Belgium, and part of Germany were approached to complete the Pediatric 
Quality of Life Inventory 4.0 (PedsQL™) questionnaire. We determined the differences between groups on PedsQL™ 
mean scores, the proportion of children with an impaired HRQoL (≥ 1 SD lower than the healthy norm), the proportion of 
problems on individual items of the PedsQL™, and the effect of time on current treatment. Linear regression models were 
used to explore determinants of HRQoL.
Results 192 out of 278 patients (20% preemptive transplant, 58% non-preemptive transplant, 22% dialysis) filled in the 
PedsQL™ (response rate 69%). Independent of treatment modality, patients had significantly lower mean scores and con-
sequently higher proportions of impaired HRQoL on almost all domains compared to the healthy norm and other chronic 
health conditions. Patients with a preemptive transplant only reported higher scores on physical health compared to the 
other treatment modalities. Having comorbidities was the most important determinant associated with lower HRQoL scores.
Conclusion Dialysis and renal transplantation both have a severe impact on the HRQoL of children with ESRD. Physicians 
should be aware of this continuous burden. Furthermore, to develop tailored interventions for children with ESRD, qualita-
tive studies are needed to gain more insight in the determinants of HRQoL in the different treatment modalities.
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Introduction
End-stage renal disease (ESRD) in children is a serious 
and life-threatening disorder. Renal transplantation is 
considered to be the optimal mode of renal replacement 
therapy (RRT) on all outcome aspects [1]. Successful 
transplantation most closely replicates the normal pro-
cess of waste removal [2, 3]. In addition, transplantation 
attenuates the constraints imposed by maintenance dialysis 
therapy, such as severe dietary and fluid restriction and 
frequent hospital visits. Physicians therefore generally 
aim for preemptive transplantation, i.e., renal transplanta-
tion without receiving dialysis before [4]. Unfortunately, 
several technical, social, or immunological hurdles to 
transplantation may force physicians to initiate dialysis 
treatment [5].
Apart from the physical strain, the social implications 
of chronic RRT may even be more damaging in children. 
Refrainment of school attendance and participation in 
peer-related activities may severely compromise acquaint-
ance of autonomy and academic skills [6, 7]. Assessment 
of health-related quality of life (HRQoL) may help to 
understand how children in different treatment modalities 
experience their illness and to identify potential factors of 
adverse experiences. Nevertheless, studies investigating 
HRQoL in children with ESRD are scarce, performed in 
relatively small numbers of patients and their results with 
respect to the effect of treatment modality are conflict-
ing [8–12]. As a consequence, uncertainty exists to what 
extent renal transplantation indeed improves HRQoL in 
comparison to dialysis treatment in the pediatric ESRD 
population.
Therefore, we conducted a comprehensive study in a 
large cohort of children with ESRD that comprised all 
pediatric patients in the Netherlands, Belgium, and part 
of Germany. The aims were to assess HRQoL across three 
RRT modalities (preemptive transplant, non-preemptive 
transplant, and dialysis) in comparison with the healthy 
norm and other chronic health conditions, to examine 
the percentage of children with an impaired HRQoL, to 
explore specific problems, the effect of time on current 
treatment, and medical and psychosocial determinants.
Methods
Study design and procedures
This international HRQoL study was designed as a cross-
sectional study within the Renal Insufficiency Therapy in 
Children: Quality Assessment and Improvement project 
(RICH-Q project) [13]. The RICH-Q database comprised 
medical and psychosocial characteristics of all pediatric 
ESRD patients from 2007 onwards in the Netherlands and 
Belgium and, from 2011, all children with ESRD treated 
in the center of Cologne, Germany. The HRQoL assess-
ment was conducted utilizing the PedsQL™ Generic Core 
Scales 4.0 (PedsQL™) questionnaire. For this study, spe-
cific patients and the first completed questionnaire after a 
patient had spent at least 6 months on their current treat-
ment modality was included in the current study. The 
inclusion criteria for patients in this study were patients 
with ESRD between 8 and 18 years who spent at least 
6 months on their current treatment modality (preemptive 
transplantation, non-preemptive transplantation, or dialy-
sis) between October 1, 2007 and December 31, 2014. 
Patients were excluded from the current study if they were 
younger than 8 years old and if they had spent < 6 months 
on their current treatment modality. Patients who met the 
inclusion criteria for this study, but either did not give 
informed consent or did not fill in the PedsQL™ are called 
‘non-participants’.
We obtained ethical approval from the ethics boards of 
all 11 participating hospitals (Emma Children’s Hospital 
AMC (Amsterdam), Erasmus MC Sophia (Rotterdam), 
Radboud University Nijmegen Medical Centre, University 
Medical Centre Utrecht, Hôpital Universitaire des Enfants-
Reine Fabiola (Brussels), Centre Hospitalier Universitaire 
de Liège, University Hospital Leuven, University Hospital 
Antwerp, Ghent University Hospital, University Medical 
Centre (Bonn), University Hospital Cologne).
Clinical characteristics and socio‑demographic data
Data on clinical characteristics were collected from the 
RICH-Q database: age, gender, mode of RRT, time in RICH-
Q database, time on RRT, time on current treatment modal-
ity, the presence of comorbidities, and number of treatment 
changes. Comorbidity was defined as impairment in any 
organ other than the kidney or the involvement of a psychi-
atric condition.
Socio-demographic data of all participants and parents 
were collected at inclusion in the RICH-Q database using 
a questionnaire completed by one parent or caregiver on 
the following items: ethnic background (western vs. non-
western), parental marital status, highest educational attain-
ment of the parents, and country of residence. Educational 
attainment was categorized according to the highest success-
fully completed level of schooling: high level (high-level 
vocational training, “Hoger Beroeps Onderwijs,” “Fach-
hochschule,” or university) versus intermediate or low 
level. According to the definition of Statistics Netherlands 
[14], children were considered to be non-Western if they 
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themselves or one or both parents had been born outside 
Western Europe.
PedsQL™ Generic Core Scales 4.0
The PedsQL™ Generic Core Scales 4.0 is a 23-item, vali-
dated measure evaluating HRQoL of children by youth 
self-report and parent proxy-report. For this study only 
self-reports of children aged 8–18 years old were used. 
The questionnaire includes four subscale scores (physical, 
emotional, social, and school functioning) and yields a total 
HRQoL score and a psychosocial health summary score. The 
23 items are answered on a 5-point Likert scale (1 = ‘‘never 
a problem’’ to 5 = ‘‘almost always a problem’’ over the past 
month) and reverse-transformed to a 0 to 100 metric, with 
higher scores representing better HRQoL. This measure has 
demonstrated good reliability and validity across pediatric 
populations, with internal consistency estimates ranging 
from .68 to .90 (Cronbach’s α) [15–17]. The reliability in 
our study ranged from  α .79 to .92. Previous research pro-
vided Dutch data on a healthy norm and on other chronic 
health conditions [18].
Statistical analysis
Baseline characteristics between the three treatment modali-
ties were compared using Chi-square tests and independent t 
tests for categorical and continuous variables, respectively.
HRQoL outcomes were examined as follows. First, inde-
pendent t tests were performed to compare the mean HRQoL 
scores between the three treatment modalities, with those in 
the healthy norm and with those in other chronic health con-
ditions. Second, the percentages of patients with impaired 
HRQoL for all treatment modalities were compared with 
those of the healthy norm. Scores ≥ 1 SD below the mean of 
the healthy norm were considered as impaired. By defini-
tion, the prevalence of impaired HRQoL in the healthy norm 
is on average 16% for each domain. Chi-square tests were 
performed to compare the proportion of children impaired 
on HRQoL between the three treatment modalities and the 
healthy norm. Third, we studied the 23 individual items 
included in the PedsQL™ and calculated the proportion of 
patients who reported “often a problem” or “almost always 
a problem” on each item separately. Fourth, to assess the 
effect of time on current treatment, scores of patients who 
had received their current treatment for < 1 year were com-
pared with those ≥ 1 year using independent t tests. Finally, 
multivariable linear regression analyses were performed to 
explore the association between HRQoL scores and poten-
tial determinants (age, gender, treatment changes, time on 
current treatment, treatment modality, presence of comor-
bidities, country of residence, marital status parents, edu-
cation attainment, non-Western background). To include 
the appropriate determinants, univariate analyses were per-
formed. Variables with P < .30 in one of the domains were 
included in the final regression analysis. Age and gender 
were included in all final regression analyses. Standardized 
regression coefficients (β) are reported, which express the 
strength of the association between the predictor variables 
and outcomes. For each regression model, the explained var-
iance (R2) was determined, and it was tested using the F test. 
An effect size of explained variance of 0.02 was considered 
as small, 0.13 as medium, and 0.26 as large.
A significance level of 0.05 was used for all analyses. We 
used SPSS 22.0 for windows (SPSS Inc., Chicago, Illinois) 
for all statistical analysis.
Results
Between October 2007 and December 2014, 278 children in 
the RICH-Q database met our inclusion criteria. Participants 
were divided into three groups based on their current treat-
ment and treatment history: (1) patients with a preemptive 
renal transplant, i.e., without prior dialysis treatment, (2) 
patients with a non-preemptive renal transplant, i.e., after 
a period of time spent on dialysis, and (3) patients receiv-
ing dialysis (hemodialysis or peritoneal dialysis). Informed 
consent for HRQoL assessment was given by 254 children 
or their parents if children were < 12 years (91%). Of the 
278 eligible children, 192 completed the PedsQL™ ques-
tionnaire (overall response rate 69%) after being 6 months 
on their current treatment. The 23 children and their parents 
who did not give their informed consent and the 63 non-
responders together are denoted as non-participants (N = 86).
Medical and socio-demographic characteristics of the 
participants according to their treatment modality are pre-
sented in Table 1. The study sample included 38 (20%) 
children with a preemptive renal transplant, 112 (58%) chil-
dren with a non-preemptive renal transplant, and 42 (22%) 
children receiving dialysis. Compared to the other two 
modalities, preemptively transplanted patients less often had 
comorbidities and had the highest proportion of parents with 
a high level of education. Patients on dialysis were older, 
more often from non-Western origin and had the lowest 
proportion of parents with a high-level educational degree.
Mean HRQoL scores
Mean scores (SD) for each PedsQL™ domain of patients, 
the healthy norm, and other chronic health conditions are 
presented in Table 2. No differences were found between 
the three treatment modalities and healthy norm as well 
as the three treatment modalities and other chronic health 
conditions on gender. Patients on dialysis were older, more 
often from non-Western origin and had a lower proportion of 
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parents with a high-level educational degree than the healthy 
norm and other chronic health conditions. Compared to the 
healthy norm, non-preemptively transplanted patients were 
more often from non-Western origin and had a lower propor-
tion of parents with a high-level educational degree.
Overall, patients reported significant lower scores com-
pared to the healthy norm and other chronic health condi-
tions. Regarding physical health, preemptively transplanted 
patients disclosed similar scores compared to the other 
chronic health conditions. Preemptively transplanted patients 
Table 1  Medical and socio-demographic characteristics of participants according to treatment modality
1 Significant difference between preemptive transplant and dialysis (P < .05)
2 Significant difference between non-preemptive transplant and dialysis (P < .05)
3 Significant difference between preemptive transplant and non-preemptive transplant (P < .05)
*Significant difference between dialysis and healthy norm and other chronic health conditions (P < .05)
^ Significant difference between non-preemptive transplant and healthy norm (P < .05)
α Preemptive transplant: 21% missing data. Non-preemptive transplant: 24% data missing. Dialysis: 26% missing data
β Preemptive transplant: 18% missing data. Non-preemptive transplant: 32% missing data. Dialysis: 26% missing data
Preemptive 
transplant 
(N = 38)
Non-preemptive 
transplant (N = 112)
Dialysis (N = 42) Healthy norm (N = 340) Other chronic 
health conditions 
(N = 51)
Age at time of  investigation1,2,*
Mean (SD) 12.8 (3.1) 13.1 (3.6) 15.0 (2.9) 12.9 (2.3) 13.0 (2.2)
Median (range)1,2,* 13.0 (8.1–18.5) 13.7 (8.0–19.0) 15.9 (8.4–18.6) 12.8 (8.0–18.0) 13.0 (8.1–16.5)
N (%) N (%) N (%)
Gender F/M 17 (45)/21 (55) 55 (49)/57 (51) 20 (48)/22 (52) 102 (55)/84 (45) 29 (56)/22 (44)
Time in RICH-Q database (months)
  0–6 0 (0) 0 (0) 5 (12)
  6–11 20 (53) 13 (12) 15 (36)
  12–24 14 (37) 50 (44) 15 (36)
  > 24 4 (10) 49 (44) 7 (16)
Time on RRT 2,3
6–11 months 19 (50) 2 (2) 17 (40)
12–24 months 14 (37) 30 (27) 10 (24)
> 24 months 5 (13) 80 (71) 15 (36)
Time on current treatment modality (months)
 6–11 19 (50) 59 (53) 17 (40)
 12–24 14 (37) 35 (31) 10 (24)
 > 24 5 (13) 18 (16) 15 (36)
Presence of  comorbidities1,3 1 (3) 59 (53)
 Cardiovascular disease 0 (0) 7 (6) 18 (43)
 Neurological  involvement1,3 0 (0) 17 (15) 4 (10)
 Gastro-intestinal disease 0 (0) 5 (5) 6 (14)
 Urogenital disorder 1 (3) 0 (0) 0 (0)
 Underlying syndrome 0 (0) 9 (8) 0 (0)
 Psychiatric condition 0 (0) 3 (3) 2 (5)
Two or more treatment  changes1,3 – 40 (36) 12 (29)
Non- Western  background1,2,*,^ 6 (16) 31(28) 19 (45) 33 (18) 9 (17)
Parents married/ living  togetherα 24 (80) 57 (74) 20 (74)
High-level educational attainment 
 parents1,2,*,^,β
13 (42) 22 (29) 2 (7) 84 (45) 23 (46)
Country of  residence1,2
 The Netherlands 30 (79) 66 (59) 20 (48)
 Belgium 8 (21) 41 (37) 14 (33) 186 (100) 51 (100)
 Germany 0 (0) 5 (4) 8 (19)
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and patients on dialysis reported similar scores compared to 
the healthy norm on emotional functioning. Preemptively 
transplanted patients scored significantly higher than both 
non-preemptive transplant and dialysis patients on physical 
health. No statistically significant differences were found 
across the three treatment modalities in other domains.
Proportion of patients with impaired HRQoL
Impaired HRQoL was significantly more often found in all 
three treatment modalities compared to the healthy norm for 
all domains and was equally prevalent in all three treatment 
modalities (Fig. 1).
Table 2  Mean HRQoL scores of children on RRT compared with healthy norm and other chronic health conditions
Independent sample t tests
α This group included patients with asthma (36%), congenital defect (14%), skin disease (6%), migraine (6%), and other diseases (38%)
*Versus healthy norm P < .05
**Versus healthy norm P < .001
^ Versus other chronic health conditions P < .05
^^Other chronic health conditions P < .001
1 Significant difference between preemptive transplant and dialysis
2 Significant difference between preemptive transplant and non-preemptive transplant
Subscale Preemptive transplant Non-preemptive trans-
plant
Dialysis Healthy norm Other chronic 
health  conditionsα
N Mean SD N Mean SD N Mean SD N Mean SD N Mean SD
8–18 year old
 Total score 38 71.2**,^ 17.8 112 68.5**,^^ 16.7 42 69.1**,^ 19.4 340 82.7 8.9 51 78.9 9.4
 Physical health 38 78.6*,1,2 18.0 111 70.4**,^^ 20.5 42 64.0**,^^ 25.7 340 85.9 9.0 51 81.6 12.0
 Emotional functioning 38 71.3 20.9 112 69.3**,^ 20.9 42 70.8 21.5 340 77.1 14.3 51 75.2 15.3
 Social functioning 38 75.7**,^ 21.0 112 74.2**,^^ 20.1 42 74.0**,^ 21.1 340 88.1 12.0 51 83.3 12.8
 School functioning 38 64.0**,^ 19.3 107 63.2**,^^ 18.2 40 65.5* 23.7 340 77.6 12.3 51 73.8 14.5
 Psychosocial health 38 70.4**,^ 17.5 112 68.5**,^^ 16.8 42 69.8**,^ 18.3 340 81.0 10.3 51 77.5 10.2
Fig. 1  Proportion of chil-
dren with impaired HRQoL 
(PedsQL™ score > 1 SD below 
the healthy norm). Dotted line 
represents the 16% of the Dutch 
healthy norm with impaired 
quality of life according to their 
PedsQL™ score. Patients in 
all three treatment modalities 
reported more often impaired 
HRQoL in all domains com-
pared with the healthy norm 
(P < .05)
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Individual PedsQL™ items
The proportion of patients who reported “often a problem” 
or “almost always a problem” for individual PedsQL™ items 
is presented in Table 3 for each item separately. The items “I 
miss school to go to the doctor or hospital” and “I cannot do 
things that other kids my age can do” were the most reported 
problems in all three treatment modalities.
Impact of time on current treatment on HRQoL
Group differences between the three treatment modalities 
on mean scores (SD) from patients who received their cur-
rent treatment for < 1 year compared to scores from patients 
who had been on the same treatment ≥ 1 year were assessed 
(Table 4). Similar scores in all domains were found among 
dialysis and preemptively transplanted patients. Non-
preemptively transplanted patients who had received their 
graft ≥ 1 year ago reported significantly lower scores com-
pared to patients who had been transplanted < 1 year ago 
on the total score, social functioning, school functioning, 
and psychosocial health domain scores. Compared to the 
healthy norm, all three treatment modalities had significantly 
lower total HRQoL scores regardless of they had spent less 
or more than 1 year on their current treatment.
Determinants of HRQoL
The presence of comorbidities was the only determinant 
associated with lower scores in almost all HRQoL domains, 
except for school functioning. Furthermore, having single 
parents was associated with lower HRQoL scores on emo-
tional functioning.
Discussion
In this international multicenter study covering all cent-
ers in the Netherlands, Belgium, and a small part of Ger-
many, impaired HRQoL was found in children with ESRD. 
Except for higher scores on physical health in patients with 
a preemptive transplant, similar HRQoL scores across all 
Table 3  Proportion of patients reporting “often a problem” or “almost always a problem” on the PedsQL™ subscales
Domain Items Preemptive 
transplant
Non-
preemptive 
transplant
Dialysis Healthy norm Other chronic 
health condi-
tions
% % % % %
Physical health It is hard for me to walk more than one block 8 12 17 0 0
It is hard for me to run 8 20 25 2 6
It is hard for me to do sports activity or exercise 17 15 29 2 8
It is hard for me to lift something heavy 8 20 24 3 2
It is hard for me to take a bath or shower by 
myself
8 6 26 0 0
It is hard for me to do chores around the house 3 14 17 0 2
I hurt or ache 5 7 12 5 18
I have low energy 10 20 24 4 8
Emotional functioning I feel afraid or scared 6 11 5 3 6
I feel sad or blue 3 9 10 5 12
I feel angry 21 16 20 3 8
I have troubling sleeping 13 13 12 7 6
I worry about what will happen to me 11 12 10 4 6
Social functioning I have trouble getting along with other kids 11 7 2 1 4
Other kids do not want to be my friend 6 3 7 3 2
Other kids tease me 3 4 0 2 4
I cannot do things that other kids my age can do 21 23 34 1 8
It is hard for me to keep up when I play with 
other kids
8 14 19 1 0
School functioning It is hard to pay attention in class 13 20 13 6 6
I forget things 19 18 23 8 6
I have trouble keeping up with my schoolwork 16 22 13 4 12
I miss school because of not feeling well 5 12 12 1 6
I miss school to go to the doctor or hospital 29 26 32 1 2
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treatment modalities were reported. All patients reported 
problems with regard to social functioning (e.g., restriction 
in activities) and school functioning (missing school due 
to hospital visits). Presence of comorbidities was the most 
important determinant for lower HRQoL scores.
In line with previous reports, this study found signifi-
cant lower PedsQL™ scores among children with ESRD 
compared to the healthy norm as well as compared to other 
chronic health conditions in almost all domains [8, 9, 11, 
12]. Given the broad consensus among health professionals 
and patients regarding the positive effect of a functioning 
transplant in the ESRD population, the hypothesis was that 
transplanted patients would report a higher HRQoL com-
pared to patients on dialysis. Indeed, patients with a preemp-
tive transplant reported higher scores on the domain of 
physical health compared to patients in the other treatment 
modalities, but we found no differences in other HRQoL 
domains across the treatment modalities. This contrasts with 
findings from adult ESRD studies which showed higher 
scores in transplanted compared to dialysis patients, espe-
cially in the domains of general health perceptions, social 
functioning, and bodily pain [19, 20], but is in accordance 
with adults who had their onset of RRT in childhood [21].
Regarding specific HRQoL domains, we found impor-
tant decrements in terms of social and school functioning in 
both dialysis and transplanted children. Up to 26% of non-
preemptively and 29% of preemptively transplanted patients 
reported problems to go to school because of hospital visits. 
Fear of losing the graft, overprotection of families, and the 
need for frequent clinical check-ups may have led to these 
results [22]. With respect to impaired social functioning, 
patients receiving a preemptive transplant have not experi-
enced the benefit of transplantation compared to the dialysis 
status and may therefore suffer more from the adverse effects 
of transplantation, such as side effects of immunosuppres-
sive therapy, in particular weight gain, gingival hypertrophy, 
acne, and Cushingoid appearance. These are important but 
too often underestimated problems in transplanted patients, 
particularly for adolescents which could have an important 
impact on their perceived quality of life [23]. In addition, 
patients on dialysis may have high expectations of the bene-
fits of receiving a transplant, but may also realize after some 
time that transplantation is not a cure and goes on with its 
own burden. Our finding that non-preemptively transplanted 
patients who had received their graft ≥ 1 year ago reported 
worse scores on several domains compared to patients who 
had been transplanted < 1 year ago supports this hypothesis. 
In dialysis patients we found an opposite trend: patients who 
had received dialysis treatment for ≥ 1 year reported better 
(non-significant) HRQoL compared to patients who were 
on dialysis treatment for less than a year. This may imply 
that children on dialysis adjust to their situation over time 
and partly learn to cope with their disease and treatment. 
This change in health status is called ‘response shift’ and 
refers to a change in the meaning of one’s self-evaluation 
of a target construct [24]. This change in health status could 
be the result from changes in internal standards, values, and 
redefinition of the target construct. Future research should 
focus on response shift in the pediatric ESRD population. 
Furthermore, a disease-specific assessment instrument could 
shed light on more specific issues that patients with ESRD 
are facing. The PedsQL™ 3.0 ESRD module was developed, 
using the PedsQL methodology, to obtain detailed informa-
tion about what may impact the HRQoL of pediatric patients 
with ESRD [25]. This instrument contains seven domains: 
general fatigue, about my kidney disease, treatment prob-
lems, family and peer interaction, worry, perceived physi-
cal appearance, and communication. A combination of both 
the generic and disease-specific module of the PedsQL™ 
is recommended to gain insight in the HRQoL of patients 
with ESRD [26].
In accordance with previous studies [27], the existence of 
comorbidities was the most important determinant of lower 
scores on almost all HRQoL domains. Except for having 
single parents on emotional functioning, we found no other 
socio-demographic determinants to be associated with lower 
HRQoL scores. Since we have specified different comor-
bidities but only included the existence of comorbidity in 
the regression analysis, a comorbidity index for pediatric 
patients should be developed to assign different weights to 
each comorbidity [28]. Furthermore, the literature regard-
ing determinants of HRQoL among children with ESRD is 
inconsistent, especially with regard to emotional function-
ing. Previous studies found that female gender, low parental 
educational attainment, and non-Western background were 
associated with lower HRQoL scores [9, 14, 29]. Small sam-
ple sizes and variable measures of HRQoL may contribute 
to this divergence of identified determinants in the pediatric 
ESRD population. In addition, it is possible that studies do 
not include determinants specifically important to HRQoL 
such as strategies of coping with the disease, social support, 
and psychological problems [30]. Such factors should be 
studied in more detail in the future.
Current results suggest that emphasis should be put on 
informing patients about all possible consequences and com-
plications of a renal transplantation. This might help patients 
to equip and prepare, and might also avoid unrealistic high 
expectations of life after receiving the transplant. In addi-
tion, studies have suggested that valid information is vital 
for promoting adherence to medication regimens and main-
taining graft survival [31, 32]. One of the most consisting 
findings was the frustration among children in all treatment 
modalities of not being able to keep up with peers as well as 
to equally participate in social activities and school.
Physicians should be aware of the continuous burden 
with respect to social development and school performance, 
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even after transplantation, and try to adjust their practice 
where possible in order to allow them to live life as normal 
as possible.
Limitations
Some limitations of the study should be emphasized. First, 
the participants in this study do not cover the entire pediatric 
RRT or the entire group of patients in the RICH-Q database. 
We were therefore not able to perform any comparisons 
between participants and non-participants at the moment of 
our HRQOL assessment. Nevertheless, to provide informa-
tion about potential differences between the three treatment 
modalities we compared baseline characteristics, i.e., at time 
of inclusion in RICH-Q database. Second, data of healthy 
children and children with other chronic health conditions 
were collected in the Netherlands. It is questionable whether 
these data can be used as a reference group for patients from 
Belgium and Germany. However, according to our regres-
sion analysis, country was not associated with HRQoL 
scores. Third, the relatively small dialysis and preemptively 
transplanted sample size requires us to interpret current 
HRQoL comparisons with caution. Furthermore, children on 
dialysis were older compared to the healthy norm and other 
chronic health conditions but age was not associated with 
HRQoL scores. Finally, a generic HRQoL tool was used in 
order to compare children with ESRD with healthy children 
and children with other chronic health conditions. Possibly, 
the addition of the PedsQL 3.0 ESRD module would have 
captured more disease-specific aspects of HRQoL function-
ing in the different treatment modalities.
Conclusions
Chronic dialysis and renal transplantation both could have a 
severe impact on the psychosocial development of children, 
especially on their social development and academic perfor-
mance. Even preemptive transplantation, although it is the 
most favorable option for children with ESRD in physical 
terms, can have an important impact on their HRQoL. Physi-
cians should be aware of this and adjust their practice where 
possible in order to improve autonomy development of these 
patients. Furthermore, to develop tailored interventions for 
children with ESRD, qualitative studies are needed to gain 
more insight in the determinants of HRQoL.
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